Lataa...
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
Advanced renal cell carcinoma (RCC) remains a challenging, major health problem. Recent advances in understanding the fundamental biology underlying one form of RCC, ie, clear cell (or conventional) RCC, have opened the door to a series of targeted agents, such as the tyrosine kinase inhibitors (TKI...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2921256/ https://ncbi.nlm.nih.gov/pubmed/20714356 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|